Testing on human subjects could begin in 3 months.
The man who helped turn the tide in the fight against HIV/AIDs in the 1990s now has his sights set on coronavirus. Anthony Fauci, MD, the director of NIH's National Institute of Allergy and Infectious Diseases, tells Bloomberg Lawthat a coronavirus vaccine is in the works and the first human trials might start in 3 months.
“The bad news is that it happened,” Fauci told Bloomberg Lawof the current crisis surrounding coronavirus. The World Health Organization ruled today that the Wuhan China coronavirus (as some in the media have labelled it) is not yet a global health threat, but it could soon be. “The good news is that we have considerable experience with coronaviruses. Everything we’ve learned with working with coronaviruses, with SARS and MERS, are helping us very rapidly get a jump on things with regard to this new virus.”
The new respiratory virus, which emerged from Wuhan city in China at the end of last year, has killed at least 17 people and infected about 300 more. Earlier this week the US Centers for Disease Control and Prevention (CDC) confirmedthat the virus landed in the United States. That patient, in Washington state, had visited Wuhan. There have been other outbreaks in Japan, Thailand, and South Korea.
At a press briefing Tuesday, Nancy Messonnier, director of CDC’s National Center for Immunization and Respiratory Disease, said that “NIH has always been very active in this area [investigating a coronavirus vaccine] and there is early work and early conversations.”
However, Messonnier did not underplay the challenge of creating such a vaccine. “As you know, the development of a vaccine is a complex process,” she said. “It’s not something that’s going to be available tomorrow. But there are active conversations about vaccines as well as therapeutics.”
In the meantime, hospitals and infection control professionals should take the customary precautions, as happened in the case of the Washington state patient who is now doing well.
“It’s actually important to clarify that the precautions for this patient are standard isolation precautions,” said Messonnier. “This is something many hospitals know how to do and we’re grateful that in this region in Washington State they were quite prepared for this contingency. So this is not a situation like the Dallas [Ebola] one. This is something where most hospitals in the region should have a hospital that can utilize these kinds of precautions.”
She added that “a hugely important issue” is that healthcare workers stay safe. “The health of our healthcare workers is very important to all of us,” said Messonnier.
CDC Strategies Preventing Hospital-Onset C difficile Effectiveness Inconclusive in Testing
April 15th 2024Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.
Unlocking the Power of AI in Hospital Infection Prevention: A Sustainable Approach to HAIs
April 11th 2024Read on about how, as hospitals grapple with the costly burden of healthcare-associated infections (HAIs), artificial intelligence (AI) emerges as a game-changer in revolutionizing infection prevention strategies.
Deeds to Reality: A Journey of Immigration and Obstacles With Carole W. Kamangu, MPH, RN, CIC
April 9th 2024Carole W. Kamangu, MPH, RN, CIC, shares her inspiring journey from the Democratic Republic of Congo to health care leadership in the US today. (This is the French translation of the interview with Carole W. Kamangu.)
How to Be Confident in Your Disinfection: UV-C Disinfection, Dosimeter Cards, and Audits
April 4th 2024Recent research in the American Journal of Infection Control reveals gaps in routine hospital disinfection, highlighting the need for UV-C audits. Learn how to validate UV-C dosages effectively and conduct successful audits.
CDC Strategies Preventing Hospital-Onset C difficile Effectiveness Inconclusive in Testing
April 15th 2024Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.
Unlocking the Power of AI in Hospital Infection Prevention: A Sustainable Approach to HAIs
April 11th 2024Read on about how, as hospitals grapple with the costly burden of healthcare-associated infections (HAIs), artificial intelligence (AI) emerges as a game-changer in revolutionizing infection prevention strategies.
Deeds to Reality: A Journey of Immigration and Obstacles With Carole W. Kamangu, MPH, RN, CIC
April 9th 2024Carole W. Kamangu, MPH, RN, CIC, shares her inspiring journey from the Democratic Republic of Congo to health care leadership in the US today. (This is the French translation of the interview with Carole W. Kamangu.)
How to Be Confident in Your Disinfection: UV-C Disinfection, Dosimeter Cards, and Audits
April 4th 2024Recent research in the American Journal of Infection Control reveals gaps in routine hospital disinfection, highlighting the need for UV-C audits. Learn how to validate UV-C dosages effectively and conduct successful audits.
2 Commerce Drive
Cranbury, NJ 08512